• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Implementation strategies for high impact nephrology trials: the end of the trial is just the beginning.

作者信息

Reidlinger Donna M, Johnson David W, Craig Jonathan C, McDonald Stephen P, Mallard Alistair R, Robison Laura E, Wong Germaine, Hawley Carmel M

机构信息

Australasian Kidney Trials Network, Centre for Health Services Research, The University of Queensland, Brisbane, Queensland, Australia.

Australasian Kidney Trials Network, Centre for Health Services Research, The University of Queensland, Brisbane, Queensland, Australia; Department of Nephrology, Princess Alexandra Hospital, Brisbane, Queensland, Australia; Translational Research Institute, Brisbane, Queensland, Australia.

出版信息

Kidney Int. 2022 Dec;102(6):1222-1227. doi: 10.1016/j.kint.2022.07.006. Epub 2022 Aug 1.

DOI:10.1016/j.kint.2022.07.006
PMID:35926657
Abstract
摘要

相似文献

1
Implementation strategies for high impact nephrology trials: the end of the trial is just the beginning.高影响力肾脏病学试验的实施策略：试验结束只是开始。
Kidney Int. 2022 Dec;102(6):1222-1227. doi: 10.1016/j.kint.2022.07.006. Epub 2022 Aug 1.
2
Patient-Reported Outcomes as End Points in Nephrology Trials: Designing the Right Trial for the Right Question.患者报告结局作为肾脏病学试验的终点：针对正确问题设计恰当试验
J Am Soc Nephrol. 2024 Jul 1;35(7):952-954. doi: 10.1681/ASN.0000000000000389. Epub 2024 Apr 30.
3
Novel trial strategies to enhance the relevance, efficiency, effectiveness, and impact of nephrology research.提高肾脏病学研究的相关性、效率、有效性和影响力的新型试验策略。
Kidney Int. 2020 Sep;98(3):572-578. doi: 10.1016/j.kint.2020.04.050. Epub 2020 May 25.
4
Understanding implementability in clinical trials: a pragmatic review and concept map.理解临床试验中的可实施性：实用审查和概念图。
Trials. 2021 Mar 26;22(1):232. doi: 10.1186/s13063-021-05185-w.
5
Implementability of healthcare interventions: an overview of reviews and development of a conceptual framework.医疗干预措施的实施性：综述概述与概念框架的制定。
Implement Sci. 2022 Jan 27;17(1):10. doi: 10.1186/s13012-021-01171-7.
6
Clinical trial in nephrology at hard end point?
J Am Soc Nephrol. 2004 Feb;15(2):506-8. doi: 10.1097/01.asn.0000113164.35698.49.
7
Unique Study Designs in Nephrology: N-of-1 Trials and Other Designs.
Adv Chronic Kidney Dis. 2016 Nov;23(6):351-354. doi: 10.1053/j.ackd.2016.11.006.
8
The landscape of clinical trials in nephrology: a systematic review of Clinicaltrials.gov.肾脏病学临床试验格局：Clinicaltrials.gov 的系统评价。
Am J Kidney Dis. 2014 May;63(5):771-80. doi: 10.1053/j.ajkd.2013.10.043. Epub 2013 Dec 6.
9
Do e-mail alerts of new research increase knowledge translation? A "Nephrology Now" randomized control trial.电子邮件提醒新研究成果能否增加知识转化？一项“肾脏病现在”的随机对照试验。
Acad Med. 2011 Jan;86(1):132-8. doi: 10.1097/ACM.0b013e3181ffe89e.
10
The urgent need for conducting clinical trials in pediatric nephrology globally.全球儿科肾脏病学领域开展临床试验的迫切需求。
Pediatr Nephrol. 2023 Aug;38(8):2499-2506. doi: 10.1007/s00467-023-05877-2. Epub 2023 Feb 4.

引用本文的文献

1
Mitigating Health Disparities in Transplantation Requires Equity, Not Equality.减轻移植中的健康不平等需要公平，而不是平等。
Transplantation. 2024 Jan 1;108(1):100-114. doi: 10.1097/TP.0000000000004630. Epub 2023 May 5.
2
Multi-center, pragmatic, cluster-randomized, controlled trial of standardized peritoneal dialysis (PD) training versus usual care on PD-related infections (the TEACH-PD trial): trial protocol.多中心、实用、整群随机对照试验，比较标准化腹膜透析（PD）培训与常规护理对 PD 相关感染的影响（TEACH-PD 试验）：试验方案。
Trials. 2023 Nov 14;24(1):730. doi: 10.1186/s13063-023-07715-0.
3
Unmet needs in clinical trials in CKD: questions we have not answered and answers we have not questioned.
慢性肾脏病临床试验中未满足的需求：我们尚未回答的问题以及我们未曾质疑过的答案。
Clin Kidney J. 2022 Oct 15;16(3):437-441. doi: 10.1093/ckj/sfac226. eCollection 2023 Mar.